Ampio pharmaceuticals to present at the international society for aerosols in medicine (isam) 23rd international congress

Englewood, colo., march 29, 2021 /prnewswire/ -- ampio pharmaceuticals (nyse american: ampe), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced the company will present its findings on a poster entitled, "regulatory decisions during covid-19: efficient nonclinical inhalation toxicology for a clinical program," at the upcoming 23rd international congress of the international society for aerosols in medicine (isam).
AMPE Ratings Summary
AMPE Quant Ranking